Qingtao Wang

Qingtao Wang

Auto-generated profile, based on publicly available information

Qingtao Wang

Department of Clinical Laboratory, Beijing Chao‐yang Hospital Capital Medical University Beijing China

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2022 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
RZRui Zhou
Rui Zhou
WWWei Wang
Wei Wang
Andrea PadoanAndrea Padoan
Andrea Padoan
ZWZhe Wang
Zhe Wang
XFXiang Feng
Xiang Feng
QWQingtao Wang
Qingtao Wang
Objectives: Patient-based real-time quality control (PBRTQC) has gained attention as an alternative/integrative tool for internal quality control (iQC). However, it is still doubted for its performance and its application in real clinical settings. We aim to generate a newly and easy-to-access patient-based real-time QC by machine learning (ML) traceable to standard reference data with assigned values by National Institute of Metrology of China (NIM), and to compare it with PBRTQC for clinical validity evaluation. Methods: For five representative biochemistry analytes, 1,195 000 patient testing results each were collected. After data processing, independent training and test sets were divided. Machine learning internal quality control (MLiQC) was set up by Random Forest in ML and was validated by way of both metrology algorithm traceability and 4 PBRTQC methods recommended by IFCC analytical working group. Results: MLiQC were established. As an example of albumin (ALB) at the critical bias, the uncertainty of MLiQC was 0.14%, which was evaluated by standard reference data produced by NIM. Compared with four optimal PBRTQC methods at critical bias, the average of the number of patient samples from a bias introduced until detected (ANPed) of MLiQC averagely decreased from 600 to 20. The median and 95 quantiles of NPeds (MNPed and 95NPed) of MLiQC were superior to all optimal PBRTQCs above 90% for all test items. Conclusions: MLiQC is highly superior to PBRTQC and well-suited in real settings. The validation of the model from two aspects of algorithm traceability and clinical effectiveness confirms its satisfactory performance.

29 December 2021 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Open access
RZRui Zhou
Rui Zhou
YLYu-Fang Liang
Yu-Fang Liang
HCHua-Li Cheng
Hua-Li Cheng
WWWei Wang
Wei Wang
DHDa-Wei Huang
Da-Wei Huang
QWQing-Tao Wang
Qing-Tao Wang
Objectives: Delta check (DC) is widely used for detecting sample mix-up. Owing to the inadequate error detection and high false-positive rate, the implementation of DC in real-world settings is labor-intensive and rarely capable of absolute detection of sample mix-ups. The aim of the study was to develop a highly accurate DC method based on designed deep learning to detect sample mix-up. Methods: A total of 22 routine hematology test items were adopted for the study. The hematology test results, collected from two hospital laboratories, were independently divided into training, validation, and test sets. By selecting six mainstream algorithms, the Deep Belief Network (DBN) was able to learn error-free and artificially (intentionally) mixed sample results. The model’s analytical performance was evaluated using training and test sets. The model’s clinical validity was evaluated by comparing it with three well-recognized statistical methods. Results: When the accuracy of our model in the training set reached 0.931 at the 22nd epoch, the corresponding accuracy in the validation set was equal to 0.922. The loss values for the training and validation sets showed a similar (change) trend over time. The accuracy in the test set was 0.931 and the area under the receiver operating characteristic curve was 0.977. DBN demonstrated better performance than the three comparator statistical methods. The accuracy of DBN and revised weighted delta check (RwCDI) was 0.931 and 0.909, respectively. DBN performed significantly better than RCV and EDC. Of all test items, the absolute difference of DC yielded higher accuracy than the relative difference for all methods. Conclusions: The findings indicate that input of a group of hematology test items provides more comprehensive information for the accurate detection of sample mix-up by machine learning (ML) when compared with a single test item input method. The DC method based on DBN demonstrated highly effective sample mix-up identification performance in real-world clinical settings.

1 January 2008 in Hemoglobin
Verified
Journal Article
Closed access
JLJing-Zhong Liu
Jing-Zhong Liu
HHHan Han
Han Han
JSJan P. Schouten
Jan P. Schouten
LWLirong Wang
Lirong Wang
XFXin-Ping Fan
Xin-Ping Fan
QWQing-Tao Wang
Qing-Tao Wang
The multiplex ligation-dependent probe amplification (MLPA) method was used to analyze 118 DNA samples from 90 alpha-thalassemia (alpha-thal) patients and 28 normal persons from Southern China, where the main causes of alpha-thal are three large deletions (-alpha3.7, -alpha4.2, and --SEA) and two point mutations in the alpha-globin gene cluster on chromosome 16. The results, detected by the P140B HBA kit, were in complete concordance with the results detected by multiplex polmymerase chain reaction (m-PCR) and real-time PCR. The advantages and limitations of the techniques are discussed. We concluded that MLPA was a rapid and reliable method to determine the cause of both deletional and nondeletional alpha-thal in China.

Verified
Journal Article
Open access
PDF file
JXJiatong Xu
Jiatong Xu
SZSongbiao Zhu
Songbiao Zhu
LXLina Xu
Lina Xu
Xiaohui LiuXiaohui Liu
Xiaohui Liu
WDWenxi Ding
Wenxi Ding
Haiteng DengHaiteng Deng
Haiteng Deng
Carbonic anhydrase IX (CA9), a pH-regulating transmembrane protein, is highly expressed in solid tumors, and particularly in clear cell renal cell carcinoma (ccRCC). The catalytic mechanisms of CA9 are well defined, but its roles in mediating cell migration/invasion and survival in ccRCC remain to be determined. Here, we confirmed that the mRNA expression of CA9 in ccRCC was significantly higher than that in para-carcinoma tissues from analysis of the datasets in The Cancer Genome Atlas. CA9 knockdown upregulated oxidative phosphorylation-associated proteins and increased mitochondrial biogenesis, resulting in the reversal of the Warburg phenotype and the inhibition of cell growth. Our study revealed that CA9 knockdown upregulated mitochondrial arginase 2 (ARG2), leading to the accumulation of putrescine, which suppressed ccRCC proliferation. Surfaceomics analysis revealed that CA9 knockdown downregulated proteins associated with extracellular matrix (ECM)—receptor interaction and cell adhesion, resulting in decreased cell migration. CA9 silencing also downregulated amino acid transporters, leading to reduced cellular amino acids. Collectively, our data show that CA9 knockdown suppresses proliferation via metabolic reprogramming and reduced cell migration, reaffirming that CA9 is a potential therapeutic target for ccRCC treatment.

19 October 2023 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
YLYu-Fang Liang
Yu-Fang Liang
Andrea PadoanAndrea Padoan
Andrea Padoan
ZWZhe Wang
Zhe Wang
CCChao Chen
Chao Chen
QWQing-Tao Wang
Qing-Tao Wang
RZRui Zhou
Rui Zhou
Objectives: Patient-based real-time quality control (PBRTQC), a laboratory tool for monitoring the performance of the testing process, has gained increasing attention in recent years. It has been questioned for its generalizability among analytes, instruments, laboratories, and hospitals in real-world settings. Our purpose was to build a machine learning, nonlinear regression-adjusted, patient-based real-time quality control (mNL-PBRTQC) with wide application. Methods: Using computer simulation, artificial biases were added to patient population data of 10 measurands. An mNL-PBRTQC was created using eight hospital laboratory databases as a training set and validated by three other hospitals’ independent patient datasets. Three different Patient-based models were compared on these datasets, the IFCC PBRTQC model, linear regression-adjusted real-time quality control (L-RARTQC), and the mNL-PBRTQC model. Results: Our study showed that in the three independent test data sets, mNL-PBRTQC outperformed the IFCC PBRTQC and L-RARTQC for all measurands and all biases. Using platelets as an example, it was found that for 20 % bias, both positive and negative, the uncertainty of error detection for mNL-PBRTQC was smallest at the median and maximum values. Conclusions: mNL-PBRTQC is a robust machine learning framework, allowing accurate error detection, especially for analytes that demonstrate instability and for detecting small biases.

1 February 2016 in Clinica Chimica Acta
Verified
Journal Article
Closed access
KZKuo Zhang
Kuo Zhang
HHHong Huo
Hong Huo
GLGuigao Lin
Guigao Lin
YYYuhong Yue
Yuhong Yue
QWQingtao Wang
Qingtao Wang
JLJinming Li
Jinming Li